JP2024001089A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024001089A5 JP2024001089A5 JP2023169472A JP2023169472A JP2024001089A5 JP 2024001089 A5 JP2024001089 A5 JP 2024001089A5 JP 2023169472 A JP2023169472 A JP 2023169472A JP 2023169472 A JP2023169472 A JP 2023169472A JP 2024001089 A5 JP2024001089 A5 JP 2024001089A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation
- butyloxycarbonyl
- imidazol
- sulfonamide
- iso
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025062545A JP2025106410A (ja) | 2020-04-24 | 2025-04-04 | 経口投与用の新しい遅延放出組成物 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2006074.5A GB202006074D0 (en) | 2020-04-24 | 2020-04-24 | New composition |
| GB2006074.5 | 2020-04-24 | ||
| JP2022540547A JP7418587B2 (ja) | 2020-04-24 | 2021-04-23 | 経口投与用の新しい遅延放出組成物 |
| PCT/GB2021/050993 WO2021214487A1 (en) | 2020-04-24 | 2021-04-23 | New delayed release composition for peroral administration |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022540547A Division JP7418587B2 (ja) | 2020-04-24 | 2021-04-23 | 経口投与用の新しい遅延放出組成物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025062545A Division JP2025106410A (ja) | 2020-04-24 | 2025-04-04 | 経口投与用の新しい遅延放出組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024001089A JP2024001089A (ja) | 2024-01-09 |
| JP2024001089A5 true JP2024001089A5 (https=) | 2024-04-18 |
| JP7663647B2 JP7663647B2 (ja) | 2025-04-16 |
Family
ID=71080159
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022540547A Active JP7418587B2 (ja) | 2020-04-24 | 2021-04-23 | 経口投与用の新しい遅延放出組成物 |
| JP2023169472A Active JP7663647B2 (ja) | 2020-04-24 | 2023-09-29 | 経口投与用の新しい遅延放出組成物 |
| JP2025062545A Pending JP2025106410A (ja) | 2020-04-24 | 2025-04-04 | 経口投与用の新しい遅延放出組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022540547A Active JP7418587B2 (ja) | 2020-04-24 | 2021-04-23 | 経口投与用の新しい遅延放出組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025062545A Pending JP2025106410A (ja) | 2020-04-24 | 2025-04-04 | 経口投与用の新しい遅延放出組成物 |
Country Status (26)
| Country | Link |
|---|---|
| US (4) | US11654115B2 (https=) |
| EP (2) | EP4218737A1 (https=) |
| JP (3) | JP7418587B2 (https=) |
| KR (1) | KR20230005239A (https=) |
| CN (1) | CN115811971A (https=) |
| AU (1) | AU2021258542B2 (https=) |
| BR (1) | BR112022021520A2 (https=) |
| CA (1) | CA3180850A1 (https=) |
| DK (1) | DK4138789T3 (https=) |
| ES (1) | ES2955915T3 (https=) |
| FI (1) | FI4138789T3 (https=) |
| GB (1) | GB202006074D0 (https=) |
| HR (1) | HRP20231012T1 (https=) |
| HU (1) | HUE062897T2 (https=) |
| IL (1) | IL297374B1 (https=) |
| LT (1) | LT4138789T (https=) |
| MA (1) | MA59397B1 (https=) |
| MD (1) | MD4138789T2 (https=) |
| MX (1) | MX2022013069A (https=) |
| PL (1) | PL4138789T3 (https=) |
| PT (1) | PT4138789T (https=) |
| RS (1) | RS64568B1 (https=) |
| SI (1) | SI4138789T1 (https=) |
| SM (1) | SMT202300289T1 (https=) |
| WO (1) | WO2021214487A1 (https=) |
| ZA (1) | ZA202211461B (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202004094D0 (en) * | 2020-03-20 | 2020-05-06 | Vicore Pharma Ab | New compounds and uses |
| GB202006079D0 (en) | 2020-04-24 | 2020-06-10 | Vicore Pharma Ab | New composition |
| GB202006074D0 (en) | 2020-04-24 | 2020-06-10 | Vicore Pharma Ab | New composition |
| GB202201723D0 (en) * | 2022-02-10 | 2022-03-30 | Vicore Pharma Ab | New use |
| WO2023152503A1 (en) * | 2022-02-10 | 2023-08-17 | Vicore Pharma Ab | Use of buloxibutid for the treatment of idiopathic pulmonary fibrosis |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59139317A (ja) * | 1983-01-31 | 1984-08-10 | Teisan Seiyaku Kk | 持続性のニフエジピン製剤 |
| SE9800550D0 (sv) | 1998-02-24 | 1998-02-24 | A & Science Invest Ab | A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof |
| CA2449150C (en) | 2001-05-31 | 2011-07-12 | Vicore Pharma Ab | Tricyclic compounds useful as angiotensin ii agonists |
| JP2003325642A (ja) | 2002-05-09 | 2003-11-18 | Sansho Pharmaceutical Co Ltd | 腸溶性皮膜付き硬質空カプセルと、腸溶性皮膜付き硬質空カプセルの製造方法と、腸溶性皮膜付き硬質カプセル剤 |
| US20050143435A1 (en) * | 2003-10-10 | 2005-06-30 | Solvay Pharmaceuticals Gmbh | Pharmaceutical compositions comprising a selective I1 imidazoline receptor agonist and an angiotensin II receptor blocker |
| JP2008502699A (ja) | 2004-06-14 | 2008-01-31 | セプラコール・インコーポレイテッド | 肺疾患治療方法、及びそのための組成物 |
| PE20060777A1 (es) | 2004-12-24 | 2006-10-06 | Boehringer Ingelheim Int | Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas |
| ES2793530T3 (es) | 2014-05-19 | 2020-11-16 | Tillotts Pharma Ag | Cápsulas revestidas de liberación modificada |
| EP2946773A1 (en) | 2014-05-19 | 2015-11-25 | Tillotts Pharma AG | Modified release coated capsules |
| CN107405406A (zh) | 2015-03-02 | 2017-11-28 | 维科尔药物公司 | 用于治疗肺纤维化的血管紧张素ii受体激动剂 |
| JPWO2017022248A1 (ja) | 2015-08-04 | 2018-05-24 | 富士カプセル株式会社 | 腸溶性カプセル |
| WO2017221012A1 (en) | 2016-06-21 | 2017-12-28 | Vicore Pharma Ab | Methods and compositions for preventing or reducing the risk of cancer treatment-related cardiotoxicity |
| GB201710906D0 (en) | 2017-07-06 | 2017-08-23 | Vicore Pharma Ab | Compounds and methods for treating peripheral neuropathy |
| WO2019183513A1 (en) * | 2018-03-22 | 2019-09-26 | University Of Iowa Research Foundation | Compositions and methods for the treatment and prevention of muscular dystrophy |
| JP7044360B2 (ja) | 2018-04-02 | 2022-03-30 | 三生医薬株式会社 | ハードカプセル用コーティング剤及びそれを用いたハードカプセル剤の製造方法 |
| GB201818164D0 (en) | 2018-11-07 | 2018-12-19 | Vicore Pharma Ab | New composition |
| GB202006079D0 (en) | 2020-04-24 | 2020-06-10 | Vicore Pharma Ab | New composition |
| GB202006074D0 (en) | 2020-04-24 | 2020-06-10 | Vicore Pharma Ab | New composition |
| GB202201723D0 (en) | 2022-02-10 | 2022-03-30 | Vicore Pharma Ab | New use |
-
2020
- 2020-04-24 GB GBGB2006074.5A patent/GB202006074D0/en not_active Ceased
-
2021
- 2021-04-23 EP EP23177726.9A patent/EP4218737A1/en active Pending
- 2021-04-23 RS RS20230717A patent/RS64568B1/sr unknown
- 2021-04-23 HU HUE21724011A patent/HUE062897T2/hu unknown
- 2021-04-23 KR KR1020227040358A patent/KR20230005239A/ko active Pending
- 2021-04-23 JP JP2022540547A patent/JP7418587B2/ja active Active
- 2021-04-23 PL PL21724011.8T patent/PL4138789T3/pl unknown
- 2021-04-23 AU AU2021258542A patent/AU2021258542B2/en active Active
- 2021-04-23 WO PCT/GB2021/050993 patent/WO2021214487A1/en not_active Ceased
- 2021-04-23 SM SM20230289T patent/SMT202300289T1/it unknown
- 2021-04-23 BR BR112022021520A patent/BR112022021520A2/pt unknown
- 2021-04-23 DK DK21724011.8T patent/DK4138789T3/da active
- 2021-04-23 LT LTEPPCT/GB2021/050993T patent/LT4138789T/lt unknown
- 2021-04-23 FI FIEP21724011.8T patent/FI4138789T3/fi active
- 2021-04-23 MX MX2022013069A patent/MX2022013069A/es unknown
- 2021-04-23 MD MDE20230229T patent/MD4138789T2/ro unknown
- 2021-04-23 CN CN202180042664.2A patent/CN115811971A/zh active Pending
- 2021-04-23 IL IL297374A patent/IL297374B1/en unknown
- 2021-04-23 HR HRP20231012TT patent/HRP20231012T1/hr unknown
- 2021-04-23 PT PT217240118T patent/PT4138789T/pt unknown
- 2021-04-23 EP EP21724011.8A patent/EP4138789B1/en active Active
- 2021-04-23 CA CA3180850A patent/CA3180850A1/en active Pending
- 2021-04-23 ES ES21724011T patent/ES2955915T3/es active Active
- 2021-04-23 MA MA59397A patent/MA59397B1/fr unknown
- 2021-04-23 SI SI202130057T patent/SI4138789T1/sl unknown
-
2022
- 2022-03-17 US US17/696,997 patent/US11654115B2/en active Active
- 2022-10-19 ZA ZA2022/11461A patent/ZA202211461B/en unknown
-
2023
- 2023-04-14 US US18/300,739 patent/US12121614B2/en active Active
- 2023-09-29 JP JP2023169472A patent/JP7663647B2/ja active Active
-
2024
- 2024-09-17 US US18/887,301 patent/US20250235408A1/en active Pending
-
2025
- 2025-04-04 JP JP2025062545A patent/JP2025106410A/ja active Pending
- 2025-09-17 US US19/331,702 patent/US20260007608A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024001089A5 (https=) | ||
| US11147772B2 (en) | Timed, pulsatile release systems | |
| RU2101010C1 (ru) | Вкусовая маскировка ибупрофена полимерным покрытием | |
| JP4907765B2 (ja) | 経口医薬パルス放出剤形 | |
| TW299235B (https=) | ||
| DK175578B1 (da) | Farmaceutisk præparat med kontrolleret frigivelseshastighed | |
| JP5808670B2 (ja) | 弱塩基性薬物を含む組成物及び徐放性剤形 | |
| US20050118268A1 (en) | Timed pulsatile drug delivery systems | |
| HU199677B (en) | Process for producing retard pharmaceutical composition | |
| CN101410094A (zh) | 包含弱碱性选择性5-羟色胺5-ht3阻断剂和有机酸的药物递送系统 | |
| JPH072635B2 (ja) | 新規医薬製剤およびその製造方法 | |
| CN101977593A (zh) | 包含弱碱性药物以及有机酸的给药系统 | |
| CN114404393B (zh) | 一种拉考沙胺药物组合物及其药物制剂 | |
| CN109310642B (zh) | 美沙拉嗪的口服药物组合物 | |
| NL1008575C2 (nl) | Nieuwe formulering. | |
| WO2015055130A2 (zh) | 一种长效缓释微丸及其制备方法 | |
| CN101808665A (zh) | 阿利吉仑和缬沙坦的药物组合 | |
| HRP20231012T1 (hr) | Novi sastav s odgođenim oslobađenjem za peroralno davanje | |
| JP2025183214A (ja) | センタナファジン製剤ならびにその製造および使用方法 | |
| CN101861138A (zh) | 控释的阿奇霉素固体剂型 | |
| CN1106837C (zh) | 碱化钾盐控释制剂 | |
| KR20190092805A (ko) | 아세틸살리실산 및 란소프라졸을 포함하는 약학적 조성물 | |
| CN101120930B (zh) | 一种奥美拉唑组合物及其制备方法 | |
| KR20180135020A (ko) | 니코틴아미드의 경구 약제학적 조성물 | |
| CN101754754B (zh) | 含有包覆的含药物的颗粒的可分散药片及其制备方法 |